Table: Phoenixbio -Q1 group results

PhoenixBio

14/08/2023 07:30

Aug 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              439 mln             445 mln           2.04     
                   (-1.3 pct)          (-1.5 pct)       (-4.0 pct)  
  Operating           7 mln              89 mln           248 mln   
                   (-92.1 pct)         (+27.6 pct)      (-51.1 pct) 
  Recurring          47 mln              113 mln          250 mln   
                   (-58.2 pct)         (+54.1 pct)      (-50.9 pct) 
  Net                42 mln              103 mln          235 mln   
                   (-59.3 pct)         (+59.7 pct)      (-52.2 pct) 
  EPS               11.59 yen           31.26 yen        69.45 yen  
  EPS Diluted       8.01 yen            20.76 yen                   
  Ann Div                                  NIL              NIL     
  -Q2 div                                  NIL              NIL     
  -Q4 div                                  NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T